IntegriChain Executive and Leadership Team

November, 2026

Leadership Overview

IntegriChain has 4 executives leading key functions including commercial strategy, technology architecture, operational efficiency, and revenue growth.

Focused on optimizing pharmaceutical market access, IntegriChain delivers advanced data analytics and business process platforms to enhance profitability for global biopharmaceutical manufacturers across the entire product lifecycle.

Leadership Roles at IntegriChain

  • Chief Operating Officer - Sean Downey
  • Chief Technology Officer - Brad Burget
  • Chief Revenue Officer - Chris Hare
  • Managing Director - Walter Worsham
  • Sean Downey - Chief Operating Officer

    Sean Downey, the Chief Operating Officer at IntegriChain, directs internal business processes and service delivery frameworks. Overseeing the execution of market access services, the Chief Operating Officer ensures that operational workflows align with the needs of pharmaceutical manufacturers. This leadership role involves driving efficiency across all departments to support the management of $1 trillion in gross revenue. By optimizing resource allocation and project management methodologies, Sean Downey enhances the delivery of commercialization solutions. The Chief Operating Officer monitors performance metrics to ensure consistent service quality across all client engagements. Through strategic coordination with other C-suite leaders, the Chief Operating Officer maintains organizational agility in a rapidly changing healthcare environment. Ultimately, the Chief Operating Officer drives the operational scale required to support the company's mission of providing comprehensive data and analytics platforms to the biopharmaceutical industry.

    Brad Burget - Chief Technology Officer

    Brad Burget, the Chief Technology Officer at IntegriChain, architects the scalable data infrastructure powering the ICyte platform. Overseeing software development and engineering teams, the Chief Technology Officer ensures the seamless integration of commercial, financial, and operational data streams. This leadership role involves driving innovation in analytics capabilities to support complex biopharmaceutical lifecycle management. By prioritizing robust security and data integrity, Brad Burget maintains the trust of major biopharma brands managing over $1 trillion in gross revenue. The Chief Technology Officer directs the evolution of technical solutions, ensuring that platform performance meets the high-demand requirements of global pharmaceutical operations. Through continuous refinement of cloud-based architectures, the Chief Technology Officer enables rapid decision-making for clients. Ultimately, the Chief Technology Officer secures the technological foundation necessary for the company to deliver superior market access insights and maintain industry-leading software performance.

    Chris Hare - Chief Revenue Officer

    Chris Hare, the Chief Revenue Officer at IntegriChain, directs global sales initiatives and market expansion efforts. Overseeing the acquisition of new biopharmaceutical clients, the Chief Revenue Officer ensures that the company's commercialization and market access services reach key industry players. This leadership role involves driving revenue growth by demonstrating the value of the ICyte platform to top-tier brands. By aligning sales strategies with the specific needs of pharmaceutical manufacturers, Chris Hare secures long-term partnerships that support portfolio expansion. The Chief Revenue Officer manages the sales pipeline and monitors market penetration across diverse geographic regions. Through close collaboration with the product and marketing teams, the Chief Revenue Officer refines value propositions to address evolving industry challenges. Ultimately, the Chief Revenue Officer drives the financial success of the organization by expanding the footprint of data-driven solutions within the global biopharmaceutical market.
    Chris Hare

    Walter Worsham - Managing Director

    Walter Worsham, the Managing Director at IntegriChain, directs high-level commercialization strategies for pharmaceutical manufacturers. Overseeing complex market access initiatives, the Managing Director ensures alignment between client product portfolios and evolving healthcare regulatory landscapes. This leadership role involves driving long-term value through the integration of financial and operational data within the ICyte platform. By architecting strategic partnerships, Walter Worsham secures competitive advantages for biopharma brands navigating North American markets. The Managing Director maintains rigorous oversight of business process improvements, ensuring that all commercial activities support sustainable revenue growth. Through constant evaluation of market trends, the Managing Director optimizes service delivery models to meet the specific needs of top-tier biopharmaceutical clients. Ultimately, the Managing Director fosters an environment of operational excellence, positioning the organization as a critical partner in the pharmaceutical commercialization ecosystem.

    Explore Leadership Teams in Healthcare Software

    Frequently Asked Questions Regarding IntegriChain Top Executives and Leadership Team

    Who leads IntegriChain?
    IntegriChain is led by Sean Downey (Chief Operating Officer), along with executives such as Brad Burget (Chief Technology Officer) and Chris Hare (Chief Revenue Officer).
    Who is part of IntegriChain’s executive team?
    The executive team of IntegriChain includes leaders such as Sean Downey (Chief Operating Officer), Brad Burget (Chief Technology Officer), Chris Hare (Chief Revenue Officer) and other senior executives.
    How many executives does IntegriChain have?
    IntegriChain has 4 executives leading key business areas.
    What roles are included in IntegriChain’s leadership team?
    The leadership team of IntegriChain includes roles such as Chief Operating Officer, Chief Technology Officer, Chief Revenue Officer, Managing Director.